Arch Therapeutics (Arch Therapeutics) Days Payable : 11,908.13 (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Arch Therapeutics Days Payable?

Arch Therapeutics's average Accounts Payable for the three months ended in Mar. 2024 was $2.87 Mil. Arch Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.02 Mil. Hence, Arch Therapeutics's Days Payable for the three months ended in Mar. 2024 was 11,908.13.

The historical rank and industry rank for Arch Therapeutics's Days Payable or its related term are showing as below:

ARTH' s Days Payable Range Over the Past 10 Years
Min: 5069.44 Med: 6092.69 Max: 10736.81
Current: 10736.81

During the past 13 years, Arch Therapeutics's highest Days Payable was 10736.81. The lowest was 5069.44. And the median was 6092.69.

ARTH's Days Payable is ranked better than
95.3% of 724 companies
in the Biotechnology industry
Industry Median: 150.695 vs ARTH: 10736.81

Arch Therapeutics's Days Payable increased from Mar. 2023 (10,054.31) to Mar. 2024 (11,908.13). It may suggest that Arch Therapeutics delayed paying its suppliers.

Arch Therapeutics Days Payable Historical Data

The historical data trend for Arch Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Therapeutics Days Payable Chart

Arch Therapeutics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Days Payable

Get a 7-Day Free Trial

5,069.44

6,092.69

8,497.95

Arch Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															10,054.31	12,412.53	9,077.47	9,649.69	11,908.13

Competitive Comparison of Arch Therapeutics's Days Payable

For the Biotechnology subindustry, Arch Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Arch Therapeutics's Days Payable falls into.

Arch Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Arch Therapeutics's Days Payable for the fiscal year that ended in Sep. 2023 is calculated as

	Days Payable (A: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Sep. 2022 )	+	Accounts Payable (A: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2023 )	*	Days in Period
=	( (1.328	+	2.304)	/	2 )	/	0.078	*	365
=	1.816					/	0.078	*	365
=	8,497.95

Arch Therapeutics's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (2.772	+	2.97)	/	2 )	/	0.022	*	365 / 4
=	2.871					/	0.022	*	365 / 4
=	11,908.13

Arch Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Arch Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Therapeutics (Arch Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Therapeutics Inc (OTCPK:ARTH) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

235 Walnut Street, Suite 6, Framingham, MA, USA, 01702

Website

https://www.archtherapeutics.com

Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.

Executives

Terrence W Norchi	director, officer: President & CEO	C/O ARCH THERAPEUTICS, INC., PO BOX 748, NATICK MA 01760
Michael S Abrams	officer: CFO and Treasurer	64 RAMSHEAD ROAD, RAYNHAM MA 02767
Laurence Hicks	director	C/O ARCH THERAPEUTICS, INC., 235 WALNUT STREET, SUITE 6, FRAMINGHAM MA 01702
Guy L. Fish	director	C/O ARCH THERAPEUTICS, INC., 235 WALNUT STREET, SUITE 6, FRAMINGHAM MA 01702
Dan Yrigoyen	officer: Vice President, Sales	C/O ARCH THERAPEUTICS, INC., 235 WALNUT STREET, SUITE 6, FRAMINGHAM MA 01702
James R Sulat	director
Punit Dhillon	director	5820 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Richard E Davis	officer: CFO & Treasurer
Avtar S Dhillon	director	C/O GENETRONICS INC, 11199 SORRENTO VALLEY ROAD, SAN DIEGO CA 92121
Arthur L Rosenthal	director	100 CYBERONICS BLVD., HOUSTON TX 77058
Alan Barber	officer: Chief Financial Officer	C/O ARCH THERAPEUTICS, INC., PO BOX 748, NATICK MA 01760
William M Cotter	officer: Chief Operating Officer	C/O CLOSURE MEDICAL CORP, 5250 GREEN DAIRY RD, RALEIGH NC 27616